Homemade cereal bars with persimmons
Nutritionists say that for good health and a slim figure, you must include snacks in your diet....
Over the past few decades, the number of cases diagnosed with bronchial cancer has increased several times. In this pathological process, neoplasms are formed from the integumentary epithelium and bronchial glands, which are malignant in nature.
There is a certain list of factors that can provoke the development of the formation of an oncological process in the bronchi.
There are two main types of tumors that arise in the bronchi:
Epidermal cancer is the most common and in this case the formation is formed from large flat cells that are arranged in a spiral or polar manner. The tumor may be of low differentiation, with or without keratinization. Squamous cell carcinoma of the bronchus is highly malignant and often has a poor prognosis and low survival rate.
An undifferentiated type of cancer, in which the formation grows infiltratively, and in most cases the tumor originates directly in the lung. It consists of small cells, without signs of multilayered epithelium. They are arranged in the form of a garland or path. In some cases, small cell cancer produces extensive metastases and aggressively spreads to nearby tissues.
This form of the disease accounts for about 20-25% of all diagnosed types and is directly related to smoking. It is worth noting the high aggressiveness of such bronchial cancer, since the tumor metastasizes to distant organs, for example, the adrenal glands, brain and bones. The malignant formation is inoperable, so chemotherapy and radiation therapy are used in treatment.
In this type, the formation consists of large cells. There are two types of cancer: those with mucus secretion and those with cavities filled with atypical cells. Large cell cancer is the disease that occurs the least often, and this is for the best, since death occurs in the early stages. Oncologists note that the formation of this type is influenced by passive smoking and long-term drug addiction.
Glandular cell carcinoma is characterized by the appearance of a tumor with a well-formed structure. It is characterized by the production of mucus. The tumor occurs in the peripheral part of the lung, and in the first stages the symptoms of the disease do not appear. Bronchial adenocarcinoma metastasizes to the brain. If a tumor is diagnosed in the early stages, it can be removed through surgery.
It’s worth mentioning right away that tumor growth takes a long time, so more than one year passes before the first specific symptoms are identified from the onset of the disease. When figuring out how bronchial cancer manifests itself, it is worth noting that, according to clinical signs, the following stages are distinguished:
At the second and third stages, changes in a person’s condition may be observed that are characteristic of other diseases, for example, ARVI, pneumonia, and so on. In the later stages of cancer, signs of pulmonary failure are revealed, shortness of breath, pain in the chest and problems with the heart are noted.
Many oncological diseases have nonspecific early signs, so patients rarely come to the doctor in the first stages of the disease, when treatment is most effective. Symptoms of bronchial cancer at an early stage: coughing, decreased performance and loss of weight and appetite. Over time, signs of respiratory failure gradually increase. The first symptoms of bronchial cancer include the appearance of pain when the tumor grows into the surrounding tissue.
There are 4 stages of development of the disease and each has its own symptoms. Doctors say that treatment will give results only in the first two stages and the earlier signs of bronchial cancer are detected, the better the prognosis.
To confirm or refute the diagnosis, doctors use the following diagnostic methods: CT, MRI and X-ray. They help to identify not only the presence, but also the location and volume of the tumor. X-rays and other techniques help determine bronchial cancer, and the diagnosis also necessarily includes a general blood test to find out the level of leukocytes and ESR indicators. Cytological examination is important because it helps determine the nature of the formation.
To help the patient, doctors use conservative and surgical treatment methods. The first group includes radiation therapy, which in the final stages is used together with surgery. Irradiation is carried out for 2 months. and the total dose is up to 70 Gray. To remove a tumor without anesthesia and complex surgery, doctors, based on individual indicators, can prescribe stereotactic radiosurgery, which uses a cyberknife. This instrument emits radiation that removes tumors and metastases.
Non-small cell bronchial cancer (stage 3 and other complex stages) is treated with chemotherapy. It is used when surgery is not possible. Chemotherapy drugs are prescribed when it is necessary to treat a small cell tumor that is sensitive to such drugs. For non-small cell types, chemotherapy is used to reduce the size of the formation and pain, and also restore respiratory function. Treatment of bronchial cancer with folk remedies is impossible and very dangerous.
Surgery cannot be performed in all cases. Bronchial cancer is treated faster if the formation is completely removed, which will ensure a quick recovery for the patient. At stage 4, surgery is not performed, since metastases affect nearby tissues, and such intervention is ineffective. Surgical treatment of cancer is carried out in several ways, and the choice of option takes into account the extensiveness of the process:
It's no secret - the earlier the problem is identified, the more likely the chance of a complete recovery. If you are interested in how long people live if they have bronchial cancer, then you should know that if the tumor is identified in the initial stages and treated in a timely manner, the five-year survival rate is up to 80%. When the disease is advanced, according to statistics, approximately 30% of operated patients survive. If a person refuses treatment, then only 8% of patients survive to five years.
Bronchial cancer is a malignant neoplasm that affects the bronchi, resulting in impaired breathing processes. The risk group includes people who smoke for a long time and come into contact with vapors of harmful substances, which reduces local immunity. The prognosis is unfavorable, as the tumor grows in the lung tissue, completely affecting the organ. Only the initial stages are treatable. In other cases, a person will inevitably die.
It is not known for certain what exactly causes cancer cells to actively divide, forming a tumor. But there are prerequisites that contribute to the launch of pathological processes in the bronchi, among which the most common are:
Predisposition cannot be ruled out. If there are people with cancer in the family, then the risks of developing bronchial cancer in the presence of associated factors are high.
Considering the location of tumor formation, bronchial cancer can be of two types:
Most often, central cancer occurs, since pathological growth of the epithelium is sufficient for its progression, which is caused by constant exposure to pathogenic substances: smoke, toxins, carcinogens, vapors of pesticides.
Taking into account the peculiarities of the cellular structure, cancer can have several subtypes:
There are 4 stages of bronchial cancer, which affects further prognosis and survival:
Early diagnosis helps detect cancer in its early stages, which can be corrected with comprehensive treatment. Advanced forms of cancer cannot be treated, so the person quickly dies. It is enough to undergo a mandatory fluorography procedure annually, the images of which show the condition of the bronchi and lungs.
Symptoms of bronchial cancer depend primarily on the stage of tumor progression. There are three clinical stages:
The first symptoms that may indicate the presence of cancer are:
As cancer progresses and the tumor rapidly increases in size, clinical manifestations develop such as:
The patient's condition worsens as the tumor grows. In the absence of complex therapy, death soon develops.
There are several ways to diagnose cancer, the most common of which are:
Early diagnosis helps to identify early forms of cancer, the treatment of which is accompanied by a favorable prognosis.
The main goal in cancer treatment is to destroy cancer cells, slow their growth and development, and remove the affected area of the lung. Therapy must be comprehensive, since surgical removal of damaged areas of the lung does not guarantee a complete cure for cancer.
If the tumor is small and not prone to metastasis, part of the damaged bronchi is resected. Advanced forms of cancer require removal of a third or an entire lobe of the lung.
Chemotherapy using cytostatics can suppress the activity of cancer cells throughout the body, which reduces the activity of metastases and slows down the progression of cancer. In the process of remission, people live for years, leading a full life
Radiation therapy is prescribed in the presence of extensive lesions, including the lymphatic system, bone marrow and bone tissue. In some cases, the body cannot tolerate the increased load, which leads to death.
Inoperable tumors are practically impossible to treat. With the help of chemotherapy courses it is possible to prolong life, but it is impossible to get rid of cancer completely. The terminal stage involves the use of palliative treatment aimed at alleviating the person’s condition and relieving the consequences of respiratory failure.
As a preventive measure, it is necessary to exclude all factors contributing to the development of cancer:
Regular fluorography, which reflects the health status of the lungs, will help protect your life.
The prognosis for bronchial cancer is conditionally unfavorable. Success in treatment is achieved only in the initial forms. Survival rate is 18-30%. Life expectancy depends entirely on the progression of the tumor and its aggression towards other organs and systems.
Most often, people die from respiratory failure or pulmonary hemorrhage, which develops due to severe bronchospasm. The average life expectancy, if all doctor's recommendations are followed, is 1-2 years. This form of cancer is one of the most rapidly developing and prone to metastasis.
You need to pay attention to the first signs of bronchial cancer, which in its symptoms resembles a cold. Self-monitoring and comprehensive diagnostics will help identify the ill-fated disease at an early stage, and specially selected treatment can get rid of cancer.
Thank you
The site provides reference information for informational purposes only. Diagnosis and treatment of diseases must be carried out under the supervision of a specialist. All drugs have contraindications. Consultation with a specialist is required!
Bronchogenic carcinoma is the most common type of solid malignancy in men. In some developed countries, such as the United States, it is ahead of female breast cancer, which ranks first among female cancers. The incidence among the male population of developed countries has stopped growing, while among women lung cancer has become more frequent. This trend is explained by an increase in the number of smokers among adult and young females.
This disease is known for its negative outcome due to the lack of symptoms and the ability to spread beyond the lungs before any signs begin to appear and the disease can be detected.
It should be noted that the lungs are often affected by metastases of other organs, which appear on radiographs as a “cannonball” pattern.
A rational approach to the treatment of bronchogenic carcinoma can only be achieved through cytological (cellular) and tissue classification of tumors.
Due to the dismal prognosis of this disease, patients should not be informed of the diagnosis until confirmation has been obtained based on the results of cell or tissue analysis.
After histological or cytological diagnosis, the staging process begins, during which the location and size of the tumor in the lung is determined. Signs of damage to adjacent organs, regional lymph nodes, as well as metastases to other organs are considered. This approach helps the treating physician and oncologist (cancer specialist) determine the most effective treatment strategy with the fewest side effects for patients (see treatment of bronchogenic carcinoma).
Early diagnosis of the disease in symptomatic patients, carried out by specialists such as radiologists, pulmonologists and thoracic surgeons, who in turn were notified by a physician, is the most effective way to combat this disease. Treatment of this disease at an advanced stage is often palliative (temporarily relieving), rather than curative.
Factors that increase the incidence of cancer among smokers include starting smoking at an early age and the large number of cigarettes smoked per day. In these people, the total load of carcinogens, which may include inorganic substances (arsenic and nickel), as well as other organic substances, leads to precancerous cell changes over years of constant intoxication of the respiratory tract. These mutations occur as a result of the penetration of carcinogens into the DNA of the bronchial walls. Subsequently, ordered cell division gives way to uncontrolled tumor growth in one or more parts of the bronchial walls.
Filter cigarettes and half-smoked cigarettes may prevent the early development of bronchogenic carcinoma, but they are by no means a protection against this dangerous disease. Smoking a pipe and cigars is less likely to lead to the development of lung cancer, but loses its aura of innocence due to the more frequent development of carcinoma of the lips, larynx and esophagus.
The dangers of second-hand or side-stream cigarette smoke as a cause of lung carcinoma have been established through studies of non-smoking spouses of heavy smokers, as well as non-smoking people working in places where heavy smoking occurs. Forced and passive smokers inhale particularly high concentrations of carcinogens from sidestream smoke. However, the incidence of lung cancer among those unlucky enough to be nearby is still lower than among smokers.
Among those who smoked a little and quit, the susceptibility to the disease decreases after 10 years compared with those who do not smoke but smoked a lot before, and it is only 2.5 times less than among those who still smoke.
Exposure to dust and gas at work is a powerful causative agent of bronchogenic carcinoma. The list of hazardous inhalable substances includes asbestos, which, in addition to asbestosis (asbestos pneumoconiosis), can cause mesothelioma (cancer of the lining tissue of the lung, pleura), as well as bronchogenic carcinoma. While unfortunate non-smokers develop mesothelioma due to asbestos exposure, dust lung cancer is extremely rare in non-smoking asbestos miners. Smokers exposed to asbestos dust are 9 times more likely to develop bronchochenal carcinoma than smokers who are not exposed to asbestos dust, and 92 times more likely than non-smokers without exposure to asbestos dust.
The incidence of lung cancer in the mining industry is also associated with radiation emitted from the mine environment, dust particles from uranium, fluorspar and even iron ore. Radioactive dust contains Alpha particles and radon daughter substances, which have a high ability to change the structure of DNA and over the years cause the development of bronchogenic carcinoma. It was found that smoking is a pronounced provocateur of the development of lung cancer among workers of these mines.
Other industrial substances, such as nickel, chromium and arsenic salts, which are used in metal cleaning, are also carcinogenic.
Genetic predisposition to the development of bronchogenic carcinoma, although it is difficult to give actual figures, will undoubtedly contribute to the occurrence of this dangerous disease in a small group of people with a negative family history of cancer of any kind.
Environmental pollution, although clearly implicated in the development of chronic obstructive pulmonary disease and worsening asthma, has not been shown to be a compelling factor in the development of lung cancer.
Incidental discovery of bronchogenic carcinoma during x-ray examination for other purposes reveals malignant neoplasms in the lung at an early stage. This dangerous disease manifests itself according to one of three mechanisms:
Local manifestations are cough and sputum production due to the endobronchial (intrabronchial) localization of the tumor. This pathology can lead to the appearance of a “metallic” cough tone in patients suffering from chronic cough. Obstruction of normal mucus drainage and subsequent recurrent respiratory tract infections may result in recurrent bronchitis, pneumonia, and lung abscess. These manifestations should alert patients and force them to visit a doctor and get a chest x-ray, especially for smokers over 40 years of age.
The development of hemoptisis or hemoptysis due to the destruction of the bronchial wall by the tumor causes the patient to experience a completely expected anxiety state. Bleeding tumors are usually detected during bronchoscopy, since this examination becomes mandatory if fluorography reveals a tumor formation or destruction of a lung lobe due to bronchial blockage. Large malignant neoplasms located in the central part of the lung usually cause obstruction of the main airway with subsequent destruction of one or more lobes or the entire lung. Such patients will complain of increasing shortness of breath or wheezing that does not improve with conventional treatment with bronchodilators.
Patients report pain when metastases have spread to the chest: the bones of the thoracic (chest) wall and the nerve endings located above the top of the lung.
Damage to the pleura (the thin layer of cells lining the surface of the lung and the inside of the chest wall) can cause pain when inhaling. When a large amount of fluid accumulates in the pleural cavity, the pain is muffled, but the pressure on the lung located underneath increases, which leads to shortness of breath. Experienced doctors, when examining the chest, will be able to detect effusion in the pleural cavity, lung atelectasis (collapse of lung tissue or part of it), or even partial blockage of the main airways.
The spread of metastases from lung tumors to distant organs such as the brain, bone damage accompanied by fractures and pain, as well as frequent asymptomatic damage to peripheral organs, can only be detected through appropriate research methods.
It is essential that at-risk patients, especially those over 40 years of age, consult their GP or pulmonologist as soon as they begin to experience new symptoms for which they cannot find an obvious explanation. Subtle manifestations of the disease such as loss of weight and appetite, unexplained anemia and chronic general malaise should prompt smokers to seek professional help. However, there is no evidence that regular annual clinical examination and fluorography of healthy populations can prevent high mortality and prevalence rates by diagnosing the disease at an early stage. The costs of these procedures are also prohibitively high compared to the positive outcome.
Preoperative assessment of patients by pulmonologists and thoracic surgeons using x-rays, bronchoscopy and cytology is carried out to classify patients according to the tumor/lymph node/metastasis system. Selecting patients with a localized form of the disease and planning their surgery, subject to general good health and normal lung function in patients of any age, can ensure survival after surgery with subsequent full life. In developing countries, lack of preoperative assessment and surgical and postoperative care results in up to 5% of those surviving 5 years after surgery.
Certain types of malignant neoplasms, such as adenocarcinoma, cannot be treated with radiotherapy, and such as small cell carcinoma show immediate but short-term results after this treatment. Extensive radiotherapy, which is designed and administered to maximize patient survival, may have immediate and delayed side effects. Palliative radiation therapy for the primary tumor and its metastases in the bones and brain usually provides rapid but short-term relief of the disease and allows patients and their families several weeks to several months to resolve all necessary matters.
Once again, we would like to draw your attention to the fact that this method of treating small cell carcinoma gives a temporary result, and chemotherapy for other types of lung malignancies usually does not bear significant fruit.
It is important to remember that the life expectancy of patients with bronchogenic carcinoma is short. Treatment should not be planned that severely limits the fullness of life that the patient may not enjoy for long, even if such therapy pursues good goals. The support of family, friends, home hospice and other professional organizations should not be underestimated, because the patient will be surrounded by their care throughout his last days and weeks of life. Through their efforts, temporary relief will be achieved in the health of a person suffering from lung cancer when medical science has recognized its own defeat.
Bronchogenic carcinoma stubbornly resists any research and scientific approaches to improve its terrible outcome. The positive is that it is hoped that, by being informed, the public will make informed decisions about tobacco smoking in the future, resulting in a reduction in the spread of the disease.
There is no better advice to young people than to stay away from smoking, as this habit is the cause of one of the fatal diseases that long-term smokers cannot avoid.
It has been proven that lifestyle plays a major role in the development of most pathologies. Bronchial cancer is precisely the disease for which the person himself is to blame. Everyone has heard about the effect of smoking on the condition of the lungs, but most ignore this information.
Bronchopulmonary cancer includes cancer of the bronchi and lung tissue itself. This is a malignant tumor that develops from the epithelium of the bronchi of various sizes. It is most often found in people over 45 years of age with a long history of smoking. Very quickly it metastasizes to the liver, kidneys, adrenal glands, bones, and pleura.
Bronchi are part of the lower respiratory tract, tubular formations that start from the trachea with two main ones - right and left, branch repeatedly and form the bronchial tree. With each subsequent branch their diameter decreases.
The wall consists of three layers:
The function of the bronchi is to conduct air. They continue to warm and moisturize it, and also trap dust particles and microbes with the help of epithelial cilia and synthesized mucus. The vibration of the cilia occurs in the direction of the upper respiratory tract, in this way mucus and harmful impurities are removed.
The bronchi are involved in immune defense and detoxification of certain dangerous substances.
Determining the type of carcinoma is necessary to choose treatment tactics and determine the prognosis for the patient.
Central Cancer is divided into three types:
Peripheral affects small caliber bronchi and alveoli, is divided into several types:
Separately allocate atypical growth forms:
Detecting a tumor at a certain stage allows us to make prognoses for further treatment.
Main stages
Surgical treatment involves removing part of an organ with a cancerous tumor. At the initial stages, the efficiency reaches 35%. The choice of the volume of intervention depends on the prevalence of the process.
Removal of the entire lung– pneumonectomy, radical surgery. The decision about it is made after thoracotomy and revision of the chest cavity for the presence of metastases and altered lymph nodes.
Sometimes, in a widespread process, it is necessary to remove the lung along with parts of the chest, diaphragm, and pericardium. Be careful when performing the operation, because the vagus nerve and the superior vena cava are located close to the root of the lung, and the inferior vena cava is located below the diaphragm.
Chemotherapy used as an independent treatment method or in combination with surgery and radiation therapy. When carried out before surgery, it reduces the size of the carcinoma and the number of metastases; after surgical treatment, it destroys the remaining tumor cells.
Ineffective for non-small cell cancer, can be used as palliative care for inoperable tumors.
Radiation therapy carried out to curb the progression of the disease. Used for any morphological forms. Radiation is given either from the outside through the chest or from the inside.
This uses a radioactive substance sealed in a special container. External irradiation is carried out 4-5 times a week for several weeks. The dose is determined by the doctor individually. With concomitant severe lung diseases, the use of radiation therapy aggravates the condition.
Unique footage of a real operation with detailed comments from a specialist in this video:
When a tumor is detected in the early stages and treated in a timely manner, the 5-year survival rate is up to 80%. Advanced cancer leaves only 30% of those operated on alive. If treatment is refused, only 8% of patients survive for up to 5 years.
If you find an error, please highlight a piece of text and click Ctrl+Enter.
Bronchial cancer, or bronchogenic cancer, is a malignant formation of epithelial origin, originating from the mucous membrane of the bronchi of various diameters. In the medical literature, in describing lesions of the bronchial tree, the term “, which is identical to “bronchial cancer,” is more common.
Tracheal cancer is classified as a completely separate nosology; it is much less common. (Prevalence is tenths of a percent of the total incidence in oncology. Some details are further in the text).
Most forms of lung cancer are tumors growing from the bronchial walls, which is why these concepts are combined into one form - bronchopulmonary cancer.
example of a bronchopulmonary tumor
Malignant tumors of the bronchial tree represent a serious medical and social problem. In terms of prevalence, bronchial cancer ranks almost first in the world, second only to in some regions. Among patients with this diagnosis, men predominate, who get sick up to 10 times more often than women, and their average age ranges between 45-60 years, that is, the majority of patients are men of working age.
The number of patients is steadily growing, and up to a million new cases of bronchial cancer are registered in the world every year. The insidiousness of the disease, especially when the small bronchi are affected, consists of a long asymptomatic or low-symptomatic course, when the meager clinical picture does not alarm the patient to such an extent as to seek help from doctors. This is precisely why there is still a large number of advanced forms of pathology, when treatment is no longer effective.
The causes of bronchogenic cancer are mainly associated with the impact of external unfavorable conditions on the respiratory system. First of all, this concerns smoking, which, despite the active promotion of a healthy lifestyle, is still widespread not only among the adult population, but also among adolescents, who are especially sensitive to the effects of carcinogens.
Effect of smoking is usually delayed in time, and cancer can appear decades later, but it makes no sense to reject its role in tumor genesis. It is known that about 90% of patients with bronchogenic cancer were or are active smokers with a long history. Harmful and dangerous substances, radioactive components, tars and soot that penetrate along with tobacco smoke are deposited on the surface of the bronchial mucosa, leading to damage to the surface epithelium, the appearance of foci of metaplasia (restructuring) of the mucosa, and the development of chronic inflammation (“smoker’s bronchitis”). Over time, persistent disruption of the structure of the mucous membrane leads to dysplasia, which is considered the main “step” on the path to cancer.
Other causes of lung cancer come down to chronic bronchopulmonary pathology - inflammatory changes, bronchiectasis, abscesses, scars. Contact with asbestos is considered a very unfavorable occupational factor, which provokes not only pleural cancer, but also neoplasia of the bronchial tree.
structure of brochs
Speaking about bronchogenic cancer, we mean damage to the main (right and left bronchus), lobar, segmental and smaller bronchi. Damage to the main, lobar and segmental bronchus is called central lung cancer, and neoplasia of the distal airways – peripheral lung cancer.
The histological picture implies the identification of several forms of bronchogenic cancer:
In addition to those listed, there are also mixed forms that combine the characteristics of different structural options.
Squamous cell carcinoma considered the most common form of malignant lung tumors, which usually arises in large-caliber bronchi from areas of squamous metaplasia of the mucosa. With well-differentiated variants of squamous cell carcinoma, the prognosis can be relatively favorable.
Small cell cancer– one of the most malignant forms, characterized by an unfavorable course and high mortality. This type of tumor is prone to rapid growth and early metastasis.
Cancer of the central bronchus, lobar and segmental may look like an exophytically growing formation facing the inside of the bronchial lumen. Such a node causes symptoms due to the closure of the airway. In other cases, the tumor grows infiltratively, “enveloping” the bronchus from all sides and narrowing its lumen.
Tumor stages determined based on the size of the formation, the presence of metastases and the nature of changes in the surrounding structures. The clinic distinguishes four stages of cancer:
Signs of bronchogenic cancer are determined not only histological type and growth pattern of the tumor, but also its location. The main symptoms of bronchial cancer are cough, shortness of breath, and symptoms of general intoxication, which appear earlier in cancer of large bronchi and are absent for quite a long time in peripheral neoplasms.
Main bronchus cancer early gives symptoms in the form cough, initially dry, then with the release of purulent or bloody sputum. A feature of the course of this type of tumor is the possibility of its closing the lumen of the bronchus with a complete disruption of the flow of air into the lung tissue, which collapses and ceases to function (atelectasis).
Often, inflammation (pneumonitis) occurs against the background of atelectasis, then symptoms include fever, chills, and weakness, indicating an acute infectious process. As the tumor disintegrates, its size decreases somewhat, and bronchial patency may be partially restored, while the signs of atelectasis may become less noticeable. However, you should not calm down: after a short time, when the tumor increases again, the state of atelectasis and pneumonitis will most likely recur.
Upper lobe bronchus cancer occurs somewhat more often than tumors of the lower respiratory system. This may be caused by more active ventilation of the upper parts of the lungs with air containing carcinogenic substances.
Peripheral lung cancer, which can occur in small-caliber bronchi and bronchioles, does not give any symptoms for a long time, and is often detected when the tumor is large. The first signs are often limited to a severe cough and chest pain associated with the germination of pleural neoplasia. When a tumor grows into the pleural cavity, pleurisy appears, accompanied by intense pain, shortness of breath, and fever.
In the case of a large volume of tumor tissue, accumulation of exudate in the chest cavity, displacement of the mediastinal organs occurs, which can manifest itself as arrhythmias, heart failure, and puffiness of the face. Compression of the laryngeal nerve can lead to voice impairment. As intoxication with tumor metabolic products increases, the patient loses weight, general weakness increases, and the fever becomes constant.
Tracheal cancer is considered a rare pathology, occurring in no more than 0.1-0.2% of oncology patients. The primary neoplasms of this localization are malignant cylindromas and squamous cell carcinoma. The bulk of patients are middle-aged and elderly people, more often men, as in the case of tumors of the bronchi and pulmonary parenchyma.
Up to 90% of tracheal cancer patients suffer from the squamous cell type of neoplasia. The tumor usually affects the upper or lower third of the organ and grows in the form of a node facing the lumen, but infiltrative growth with significant narrowing and deformation of the tracheal wall is also possible. A dangerous localization is the location of the cancer above the site of division of the trachea into the main bronchi, since in this case closure of both bronchi and suffocation is possible.
The clinical picture of tracheal cancer consists of:
The cough in tracheal cancer is painful, dry at the beginning of the disease and with purulent sputum subsequently. Since the tumor closes the lumen of the organ and disrupts the conduction of air during inhalation and exhalation, the appearance of shortness of breath is very typical, which worries the vast majority of patients. A decrease in shortness of breath is possible when the tumor tissue disintegrates, but then it appears again.
For some time, the patient adapts to the difficulty in breathing, but as the neoplasia increases, the shortness of breath becomes more and more pronounced, threatening to develop into suffocation if the airways are completely closed. This condition is very dangerous and requires emergency medical attention.
The appearance of blood in sputum is associated with the breakdown of cancer tissue and damage to the vessels feeding the tumor. The spread of the disease to the larynx and recurrent nerves is fraught with voice impairment in the form of hoarseness or even its complete absence. Common symptoms include fever, weight loss, and weakness.
X-ray methods, including CT, are traditionally used to detect tracheal and bronchial cancer. To clarify the nature of the spread of neoplasia, an MRI is performed. A general blood test can detect an increase in the level of leukocytes, an acceleration of ESR, and a cytological examination of sputum can reveal malignant cancer cells in it.
Like any other tumor, bronchial cancer of any size can be removed by surgery, radiation, or chemotherapy. For most patients, a combination of these methods is possible, but if there are contraindications to surgery, preference will be given to conservative methods.
Surgical treatment is considered the most effective, as it gives the best results for small tumors detected in the early stages of development. The larger the cancerous node, the more it has grown into the surrounding tissue, the more difficult it will be to get rid of the disease, and the risk of surgical complications in some cases does not allow the doctor to perform the operation at all.
Interventions on the respiratory organs are always complex and traumatic; they require not only good preparation of the patient, but also highly qualified surgeons. For bronchial cancer it is possible to perform:
Pulmonectomy– the most radical way to get rid of bronchial cancer, which involves removing the entire lung with mediastinal lymph nodes and tissue. If the tumor invades large vessels or the trachea, it may be necessary to resect a section of the trachea, inferior vena cava and aorta. Such an intervention requires adequate preparation of the patient and relatively good general condition, so not every patient, especially the elderly, can undergo a total pneumonectomy.
Contraindications to radical surgery are:
Old age is not an obstacle to surgical treatment if the patient’s general condition is satisfactory, but some patients themselves tend to refuse surgery, fearing complications or considering it useless.
For localized forms of cancer, it is sufficient resection section of the bronchus or removal of a lobe of the lung - lobectomy, bilobectomy(two lobes, only if the right lung is affected). The best results are achieved when treating differentiated tumors, however, small cell cancer detected at an early stage can be subjected to surgical treatment.
If it is impossible to completely remove the tumor and lymph nodes due to the risk of complications (bleeding, for example), then a so-called conditionally radical operation is performed, when, if possible, all affected tissue is excised, and the remaining foci of cancer growth are exposed to irradiation.
Becoming increasingly common bronchoplastic operations, allowing for more economical removal of affected tissue through wedge-shaped or circular resection of the bronchus. Bronchoplastic interventions are also indicated in cases where it is technically impossible to perform a radical pneumonectomy.
Since bronchial cancer actively and early metastasizes to regional lymph nodes, in all cases, removal of the tumor is accompanied by excision of the lymph nodes that collect lymph from the affected bronchus. This approach avoids possible relapses and progression of the disease, and also increases the overall life expectancy of operated patients.
Preparation for surgery includes a balanced diet, prescription of broad-spectrum antibiotics to prevent infectious complications, correction of the cardiovascular system, and breathing exercises.
In the postoperative period, the patient is placed in a semi-sitting position and oxygen is supplied. To prevent infectious complications, antibiotic therapy is administered, and blood and air are removed from the pleural cavity to avoid displacement of mediastinal structures.
Radiation treatment is usually given in combination with surgery, but in some cases it becomes the main and only possible way to help the patient. Thus, in case of inoperable cancer, refusal of surgery, or the patient’s serious condition, which excludes the possibility of tumor removal, irradiation is carried out at a total dose of up to 70 Gray for 6-7 weeks. The most sensitive to radiation are squamous cell and undifferentiated forms of bronchial cancer, and not only the tumor, but also the mediastinal area with lymph nodes must be irradiated. In the terminal stages of cancer, irradiation can somewhat reduce the pain syndrome, being palliative in nature.
A new approach in radiation therapy is the use of a cyberknife (stereotactic radiosurgery), with which it is possible to remove a bronchial tumor without surgery or anesthesia. In addition, a directed radiation beam is capable of removing single metastases in the lung tissue.
Chemotherapy is usually used as for non-small cell cancer, when surgery is no longer possible, and for small cell varieties that are sensitive to conservative treatment. Non-small cell cancer does not respond well to chemotherapy, so they are used mainly for palliative purposes to reduce tumor size, pain and respiratory distress. The most effective are cisplatin, vincristine, cyclophosphamide, methotrexate, docetaxel, etc.
Small cell cancer is sensitive to cytostatics, especially in combination with radiation. For such treatment, several of the most effective drugs are prescribed in high doses, which are selected individually, taking into account the type of cancer and its sensitivity.
Combination treatment, which combines radiation, surgery and drug therapy, can increase the life expectancy of patients with bronchial cancer. Thus, preoperative irradiation and the administration of cytostatics can reduce the volume of the tumor and, accordingly, facilitate the operation. In the postoperative period, conservative therapy is aimed at preventing relapses and metastasis of cancer.
Radiation and chemotherapy are often accompanied by unpleasant side effects associated with the breakdown of cancer cells, so symptomatic therapy is required. Prescribing painkillers helps reduce pain, antibiotic therapy is designed to fight infection of the affected tissues. Infusion therapy is indicated to correct electrolyte imbalances.
In addition to traditional methods of fighting a tumor, attempts are being made to introduce new methods - photodynamic therapy, brachytherapy, cryotherapy, laser treatment, etc. Local treatment is justified for small cancers that do not extend beyond the mucous membrane and in the absence of metastases.
Treatment for tracheal cancer is usually combined. If the tumor is accessible to the surgeon’s scalpel, it is removed by excision of a fragment of the trachea (resection). If it is impossible to remove the tumor, then palliative treatment aimed at improving the patency of the organ is indicated.
In addition to surgery, radiation is given. For inoperable patients, radiation therapy becomes the main treatment method to reduce pain and improve respiratory function. Tracheal tumors are not very sensitive to chemotherapy, so chemotherapy has not been used for cancer of this organ.
The prognosis for malignant neoplasms originating in the bronchial wall is determined by the histological type and extent of the tumor. If at the first stage of the disease, timely treatment gives a 5-year survival rate of 80%, then at the third stage only a fifth of patients survive. The presence of metastases in distant organs significantly worsens the prognosis.
Prevention of bronchial cancer primarily includes quitting smoking, which is considered a major risk factor for the tumor. When working in hazardous conditions, you should carefully monitor your respiratory system and use protective equipment against dust and hazardous impurities in the air. If there are inflammatory processes in the respiratory tract, you need to promptly treat them and regularly visit a doctor.
The author selectively answers adequate questions from readers within his competence and only within the OnkoLib.ru resource. Face-to-face consultations and assistance in organizing treatment are not provided at this time.